Skip to content

Resistance and/or Endurance Training, What is Most Effective in Prevention of Cardiovascular Diseases?

Strength Training Versus Aerobic Interval Training to Modify Risk Factors of the Metabolic Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00986024
Enrollment
31
Registered
2009-09-29
Start date
2006-08-31
Completion date
2007-03-31
Last updated
2012-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Keywords

Exercise therapy

Brief summary

The aim of the present study was to evaluate the effects of aerobic interval training versus strength training or a combination of these regimes on factors comprising the metabolic syndrome in order to find the most effective exercise regime for patients with metabolic syndrome.

Detailed description

In the Western world, approximately 25% of young to middle-aged adults have metabolic syndrome. There seem to be a strong age-dependence in the prevalence of the metabolic syndrome, but the incidence rises rapidly within adolescents and middle-aged groups and follows the development of obesity in the general population. Metabolic syndrome confers an increased risk of coronary heart disease, cardiovascular disease, and premature death; therefore, effective and affordable strategies to combat the syndrome would be of great individual and social importance. Despite the general agreement that moderate-intensity physical activity for a minimum of 30 min five days per week or vigorous-intensity aerobic physical activity for a minimum of 20 min three days a week promote and maintain health, the optimal training regime to treat metabolic syndrome and its associated cardiovascular abnormalities remains uncertain.

Interventions

BEHAVIORALaerobic exercise

carried out 3 times per week for 12 weeks

BEHAVIORALstrength training

carried out 3 times per week for 12 weeks

Sponsors

Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Having metabolic syndrome according to international diabetes foundations definition (IDF).

Exclusion criteria

* Unstable angina pectoris * Uncompensated heart failure * Myocardial infarction during the past 4 weeks * Complex ventricular arrhythmias * Kidney failure

Design outcomes

Primary

MeasureTime frameDescription
proinflammatory markers12 weekscirculating interleukin-18 and interleukin-6

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026